Madison Area Lyme Support Group

  • About/Contact
  • Articles & Documents
  • Meetings
  • Petitioning the State of Wisconsin
  • Photographs
  • Videos

Archive for the ‘Inflammation’ Category

Science and Alternative Medicine Agree: It’s Probably Time You Try Acupuncture

https://sporteluxe.com/science-and-alternative-medicine-say-its-probably-time-you-try-acupuncture/  Full Article Here

Science And Alternative Medicine Agree: It’s Probably Time You Try Acupuncture

DAVID MINKOFF
October, 29 2019
image
Image: Antonika Chanel

The precise chronological origin of acupuncture as a medical procedure is unknown, but it’s thought to date back to as many as 3,000 years ago, in ancient China. Today it’s popular all around the world as a natural treatment for a variety of disorders and discomforts.

In its ancient form, the process, which involves inserting thin needles into specific areas of musculature, was based on the idea that energy imbalances in the body were the root cause of illness. While that may be true in the broadest sense, modern practitioners tend to think of acupuncture as less of a mystical intervention and more as a way of subtly stimulating the body’s nervous system….(go to link for full article)

________________

**Comment**

According to the article, acupuncture can help the following: 

  • migraines and other headaches
  • arthritis and tendinitis
  • chronic fatigue
  • respiratory illnesses
  • skin conditions
  • digestive problems
  • sleep disorders

The article also points out that according to a meta-analysis acupuncture is a good treatment for chronic pain-related insomnia, an issue many Lyme/MSIDS patients struggle with.

Category:

Gut Health, Inflammation, Pain Management, research, Treatment

Inflammatory Processes Drive Progression of Alzheimer’s and Other Brain Diseases

https://neurosciencenews.com/alzheimers-inflammation-15235/

Inflammatory processes drive progression of Alzheimer’s and other brain diseases

Neuroscience NewsNEUROSCIENCE NEWSNOVEMBER 20, 2019
Summary: The NLPR3 inflammasome and the inflammatory response it triggers play a critical role in the emergence of tau pathology.Source: DZNE

Inflammation drives the progression of neurodegenerative brain diseases and plays a major role in the accumulation of tau proteins within neurons. An international research team led by the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn comes to this conclusion in the journal Nature. The findings are based on the analyses of human brain tissue and further lab studies. In the particular case of Alzheimer’s the results reveal a hitherto unknown connection between Amyloid Beta and tau pathology. Furthermore, the results indicate that inflammatory processes represent a potential target for future therapies.

Tau proteins usually stabilize a neuron’s skeleton. However, in Alzheimer’s disease, frontotemporal dementia (FTD), and other “tauopathies” these proteins are chemically altered, they detach from the cytoskeleton and stick together. As a consequence, the cell’s mechanical stability is compromised to such an extent that it dies off. In essence, “tau pathology” gives neurons the deathblow. The current study led by Prof. Michael Heneka, director of the Department of Neurodegenerative Diseases and Gerontopsychiatry at the University of Bonn and a senior researcher at the DZNE, provides new insights into why tau proteins are transformed. As it turns out, inflammatory processes triggered by the brain’s immune system are a driving force.

A Molecular Switch

A particular protein complex, the “NLRP3 inflammasome”, plays a central role for these processes, the researchers report in Nature. Heneka and colleagues already studied this macromolecule, which is located inside the brain’s immune cells, in previous studies. It is a molecular switch that can trigger the release of inflammatory substances. For the current study, the researchers examined tissue samples from the brains of deceased FTD patients, cultured brain cells, and mice that exhibited hallmarks of Alzheimer’s and FTD.

“Our results indicate that the inflammasome and the inflammatory reactions it triggers, play an important role in the emergence of tau pathology”, Heneka said. In particular, the researchers discovered that the inflammasome influences enzymes that induce a “hyperphosphorylation” of tau proteins. This chemical change ultimately causes them to separate from the scaffold of neurons and clump together. “It appears that inflammatory processes mediated by the inflammasome are of central importance for most, if not all, neurodegenerative diseases with tau pathology.”

A Link between Amyloid Beta and Tau

This especially applies to Alzheimer’s disease. Here another molecule comes into play: “amyloid beta” (Amyloid Beta). In Alzheimer’s, this protein also accumulates in the brain. In contrast to tau proteins, this does not happen within the neurons but between them. In addition, deposition of Amyloid Beta starts in early phases of the disease, while aggregation of tau proteins occurs later.

This shows a head with a swirly background

In previous studies, Heneka and colleagues were able to show that the inflammasome can promote the aggregation of Amyloid Beta. Here is where the connection to the recent findings comes in. “Our results support the amyloid cascade hypothesis for the development of Alzheimer’s. According to this hypothesis, deposits of Amyloid Beta ultimately lead to the development of tau pathology and thus to cell death,” said Heneka. “Our current study shows that the inflammasome is the decisive and hitherto missing link in this chain of events, because it bridges the development from Amyloid Beta pathology to tau pathology. It passes the baton, so to speak.” Thus, deposits of Amyloid Beta activate the inflammasome. As a result, formation of further deposits of Amyloid Beta is promoted. On the other hand, chemical changes occur to the tau proteins resulting into their aggregation.

A Possible Starting Point for Therapies

“Inflammatory processes promote the development of Amyloid Beta pathology, and as we have now been able to show, of tau pathology as well. Thus, the inflammasome plays a key role in Alzheimer’s and other brain diseases,” said Heneka, who is involved in the Bonn-based “ImmunoSensation” cluster of excellence and who also teaches at the University of Massachusetts Medical School. With these findings, the neuroscientist sees opportunities for new treatment methods. “The idea of influencing tau pathology is obvious. Future drugs could tackle exactly this aspect by modulating the immune response. With the development of tau pathology, mental abilities decline more and more. Therefore, if tau pathology could be contained, this would be an important step towards a better therapy.”

ABOUT THIS NEUROSCIENCE RESEARCH ARTICLE

Source:
DZNE
Media Contacts:
Marcus Neitzert – DZNE
Image Source:
The image is in the public domain.

Original Research: Closed access
“NLRP3 inflammasome activation drives tau pathology”. Christina Ising et al.
Nature doi:10.1038/s41586-019-1769-z.

Abstract

NLRP3 inflammasome activation drives tau pathology

Alzheimer’s disease is characterized by the accumulation of amyloid-beta in plaques, aggregation of hyperphosphorylated tau in neurofibrillary tangles and neuroinflammation, together resulting in neurodegeneration and cognitive decline1. The NLRP3 inflammasome assembles inside of microglia on activation, leading to increased cleavage and activity of caspase-1 and downstream interleukin-1β release2. Although the NLRP3 inflammasome has been shown to be essential for the development and progression of amyloid-beta pathology in mice3, the precise effect on tau pathology remains unknown. Here we show that loss of NLRP3 inflammasome function reduced tau hyperphosphorylation and aggregation by regulating tau kinases and phosphatases. Tau activated the NLRP3 inflammasome and intracerebral injection of fibrillar amyloid-beta-containing brain homogenates induced tau pathology in an NLRP3-dependent manner. These data identify an important role of microglia and NLRP3 inflammasome activation in the pathogenesis of tauopathies and support the amyloid-cascade hypothesis in Alzheimer’s disease, demonstrating that neurofibrillary tangles develop downstream of amyloid-beta-induced microglial activation.

_________________

For more:  https://madisonarealymesupportgroup.com/2019/07/22/does-alzheimers-disease-stem-from-infection-scientists-debate-one-company-targets-gingivitis-bacterium-to-slow-alzheimers-progression/

https://madisonarealymesupportgroup.com/2018/09/11/its-time-to-find-the-alzheimers-germ/

For more on the potential connection between Alzheimer’s and tick borne illness:

https://madisonarealymesupportgroup.com/2016/06/09/alzheimers-byproduct-of-infection/ (Link to Kris Kristofferson’s case. Lyme treatment turned the Alzheimer’s completely around)

https://madisonarealymesupportgroup.com/2017/01/18/a-bug-for-alzheimers/

https://madisonarealymesupportgroup.com/2018/07/28/herpes-viruses-implicated-in-alzheimers-disease/

https://madisonarealymesupportgroup.com/2016/06/03/borrelia-hiding-in-worms-causing-chronic-brain-diseases/

https://madisonarealymesupportgroup.com/2016/08/09/dr-paul-duray-research-fellowship-foundation-some-great-research-being-done-on-lyme-disease/

https://madisonarealymesupportgroup.com/2018/03/25/a-brief-history-of-neuroborreliosis-research-dementia-an-inside-look-at-two-researchers/

https://madisonarealymesupportgroup.com/2017/10/14/lost-link-als-lyme/

https://madisonarealymesupportgroup.com/2017/06/10/the-coming-pandemic-of-lyme-dementia/

 

 

Category:

Alzheimer's, Inflammation, Lyme, Uncategorized

Link Between Inflammation & Mental Sluggishness Shown & How MSM, Systemic Enzymes, and Melatonin Can Help

https://neurosciencenews.com/inflammation-mental-sluggishness

Link between inflammation and mental sluggishness shown

Neuroscience NewsNEUROSCIENCE NEWSNOVEMBER 15, 2019

Summary: Inflammation appears to have a negative impact on attention and cognition.

Source: University of Birmingham

Scientists at the University of Birmingham in collaboration with the University of Amsterdam have uncovered a possible explanation for the mental sluggishness that often accompanies illness.

An estimated 12M UK citizens have a chronic medical condition, and many of them report severe mental fatigue that they characterize as ‘sluggishness’ or ‘brain fog’. This condition is often as debilitating as the disease itself.

A team in the University’s Centre for Human Brain Health investigated the link between this mental fog and inflammation – the body’s response to illness. In a study published in Neuroimage, they show that inflammation appears to have a particular negative impact on the brain’s readiness to reach and maintain an alert state.

Dr Ali Mazaheri and Professor Jane Raymond of the University’s Centre for Human Brain Health, are the senior authors of the study. Dr Mazaheri says:

“Scientists have long suspected a link between inflammation and cognition, but it is very difficult to be clear about the cause and effect. For example, people living with a medical condition or being very overweight might complain of cognitive impairment, but it’s hard to tell if that’s due to the inflammation associated with these conditions or if there are other reasons.”

“Our research has identified a specific critical process within the brain that is clearly affected when inflammation is present.”

The study focussed specifically on an area of the brain which is responsible for visual attention. A group of 20 young male volunteers took part and received a salmonella typhoid vaccine that causes temporary inflammation but has few other side effects. They were tested for cognitive responses to simple images on a computer screen a few hours after the injection so that their ability to control attention could be measured. Brain activity was measured while they performed the attention tests.

On a different day, either before or after, they received an injection with water (a placebo) and did the same attention tests. On each test day, they were unaware of which injection they had received. Their inflammation state was measured by analyzing blood taken on each day.

The tests used in the study assessed three separate attention processes, each involving distinct parts of the brain. These processes are: “alerting” which involves reaching and maintaining an alert state; “orienting” which involves selecting and prioritizing useful sensory information; and “executive control” used to resolving what to pay attention to when available information is conflicting.

The results showed that inflammation specifically affected brain activity related to staying alert, while the other attention processes appeared unaffected by inflammation.

This shows a red brain

“These results show quite clearly that there’s a very specific part of the brain network that’s affected by inflammation,” says Dr Mazaheri. “This could explain ‘brain fog’.”

Professor Raymond says,

“This research finding is a major step forward in understanding the links between physical, cognitive, and mental health and tells us that even the mildest of illnesses may reduce alertness.”

Dr Leonie Balter the first author of the study which was completed as part of her PhD, concluded:

“Getting a better understanding of the relationships between inflammation and brain function will help us investigate other ways to treat some of these conditions. For example, further research might show that patients with conditions associated with chronic inflammation, such as obesity, kidney disease or Alzheimer’s, could benefit from taking anti-inflammatory drugs to help preserve or improve cognitive function.”

“Furthermore, subtle changes in brain function may be used as an early marker cognitive deterioration in patients with inflammatory diseases.”

The next step for the team will be to test the effects of inflammation on other areas of brain function such as memory.

ABOUT THIS NEUROSCIENCE RESEARCH ARTICLE

Source:
University of Birmingham
Media Contacts:
Beck Lockwood – University of Birmingham
Image Source:
The image is in the public domain.

Original Research: Open access
“Selective effects of acute low-grade inflammation on human visual attention”. Ali Mazaheri et al.
NeuroImage doi:10.1016/j.neuroimage.2019.116098.

Abstract

Selective effects of acute low-grade inflammation on human visual attention

Illness is often accompanied by perceived cognitive sluggishness, a symptom that may stem from immune system activation. The current study used electroencephalography (EEG) to assess how inflammation affected three different distinct attentional processes: alerting, orienting and executive control. In a double-blinded placebo-controlled within-subjects design (20 healthy males, mean age = 24.5, SD = 3.4), Salmonella typhoid vaccination (0.025 mg; Typhim Vi, Sanofi Pasteur) was used to induce transient mild inflammation, while a saline injection served as a placebo-control. Participants completed the Attention Network Test with concurrent EEG recorded 6 h post-injection. Analyses focused on behavioral task performance and on modulation of oscillatory EEG activity in the alpha band (9–12 Hz) for alerting as well as orienting attention and frontal theta band (4–8 Hz) for executive control. Vaccination induced mild systemic inflammation, as assessed by interleukin-6 (IL-6) levels. While no behavioral task performance differences between the inflammation and placebo condition were evident, inflammation caused significant alterations to task-related brain activity. Specifically, inflammation produced greater cue-induced suppression of alpha power in the alerting aspect of attention and individual variation in the inflammatory response was significantly correlated with the degree of alpha power suppression. Notably, inflammation did not affect orienting (i.e., alpha lateralization) or executive control (i.e., frontal theta activity). These results reveal a unique neurophysiological sensitivity to acute mild inflammation of the neural network that underpins attentional alerting functions. Observed in the absence of performance decrements, these novel findings suggest that acute inflammation requires individuals to exert greater cognitive effort when preparing for a task in order to maintain adequate behavioral performance.

___________________

**Comment**

As most of you are aware, Lyme/MSIDS patients suffer with infection, inflammation, insomnia, and quite often – brain fog. Finding successful ways of treating each of these issues is part of treatment success.  Personally, I’ve found a number of things to help with these issues.  One is an inexpensive supplement called MSM:  https://madisonarealymesupportgroup.com/2018/03/02/dmso-msm-for-lyme-msids/  Another is called systemic or proteolytic enzymes:  https://madisonarealymesupportgroup.com/2016/04/22/systemic-enzymes/ and https://madisonarealymesupportgroup.com/2018/03/05/how-proteolytic-enzymes-may-help-lyme-msids/.  Even though I am done with Lyme/MSIDS treatment, I still take both substances as they do so many good things for the body including:

  • Control inflammation throughout the body, not just in your joints.
  • Repair and rebuild the cardiovascular system.
  • Optimize blood flow & cleanses blood of debris
  • Prevent and dissolve blood clots by dissolving fibrin
  • Dissolve plaque in your arteries and dental plaque in your mouth.
  • Clean up your immune system.
  • Minimize the impact of allergies but breaking down and removing circulating immune complexes.
  • Improve the ability to exercise and speed up recovery times.
  • Kill bacteria, viruses, and other pathogens.
  • Accelerate recovery from sprains, strains, fractures, bruises & surgery
  • Help with arthritis
  • Help with detoxification
  • Improve body alkalinity
  • Help with sinusitis and asthma
  • Help reduce MS symptoms

Another supplement I’ve taken for years is melatonin, which according to Dr. Mercola, also reduces inflammation and is neuroprotective by strengthening the blood-brain barrier.

https://articles.mercola.com/sites/articles/archive/2019/11/18/melatonin-reduces-inflammation

Melatonin Has Anti-Inflammatory and Metabolic Effects

Analysis by Dr. Joseph Mercola

November 18, 2019

melatonin benefits

STORY AT-A-GLANCE

  • Melatonin is responsible for your sleep/wake cycle and it plays an important role in fighting inflammation and weight gain
  • It affects your immune system, gut health, pain level, blood pressure and recovery from stroke and traumatic brain injury
  • You can naturally boost your melatonin levels by getting at least 15 minutes of sun exposure in the morning, among other ways
  • Melatonin has a safe track record with few adverse reactions, but its long-term effects are unknown; supplementation may not be safe for those taking certain medications or dealing with specific health conditions

Your body is a complex organism requiring quality sleep to function optimally. Your body’s circadian rhythms are a combination of biological clocks regulating everything from your metabolism to psychological functioning. One sure way to cause dysregulation of your biological clock is to skimp on sleep.

Although you have a master clock in your brain to synchronize bodily functions, every organ and cell has its own biological clock as well. In a stunning discovery published in 2017, researchers found half your genes are controlled by circadian rhythms that turn them on and off in a cyclical wave.

The whole-body circadian rhythm is largely dictated by your pineal gland, which is responsible for secreting melatonin or N-acetyl-5-methoxytryptamine. This hormone normalizes your circadian rhythm as it signals your body it’s time for sleep. The production of melatonin will depend on how much and when your body absorbs light.

The gland is located near the center of your brain and usually starts secreting melatonin near 9 p.m. Without an adequate amount of sleep and exposure to sunlight, your levels will naturally drop. Researchers have found an association between melatonin and rising levels of inflammation.

Melatonin Reduced Inflammation and Obesity Markers in Mice

In a combined effort, scientists from universities in Brazil and Italy1 sought to identify the role melatonin may have in improving disorders commonly found in those who are obese. The researchers used mice who were induced to become obese and treated them for 10 weeks with melatonin.

The objective was to determine if the hormone could effectively delay or block the damage from eating too much. The researchers found multiple results supporting their theory that melatonin supplementation could have a significant effect on the animals, including reducing triglyceride levels and total and LDL cholesterol levels.

They also found that supplementation prevented larger weight gain by reducing the formation of fat tissue and increasing the capacity to break down white fat. This combination of effects helped to prevent the hypertrophy of fat cells caused by excessive eating.

Additionally, the researchers noted the supplementation reduced a characteristic inflammatory process found in obese subjects where macrophages infiltrate adipose tissue. The mice also experienced a reduction in inflammatory related factors through a decrease in gene expression.

Overall, at the end of the 10-week trial, the group of mice eating an excessive amount without melatonin gained 49% body mass over the control group that ate a normal diet. The group of mice supplemented with melatonin increased their body mass 28% over the control group, but 13% lower than the group eating excess food without melatonin.

The researchers believe the data suggest that melatonin could be considered as a therapeutic agent to help mitigate the metabolic and inflammatory conditions triggered in those who are obese.

The Importance of Melatonin to Sleep/Wake Cycles

As with many hormones and chemicals in the body, melatonin has more than one function. The best known role it plays is in controlling your sleep/wake cycle. This well-publicized function may be due to the fact that sleep plays a significant role in your overall physical and mental health.

An estimated 40% of Americans are sleep deprived every day, with many people getting less than 5 hours of sleep per night. Millions struggle to fall asleep and others find it challenging to stay asleep. Some wake up too early in the morning.

There are a number of hazards associated with sleep deprivation; you can read about these in my past article, “Nobel Prize-Winning Science Highlights Importance of Good Sleep for Health.”

Melatonin is a marker your body uses to influence what time of day or night it thinks it is. This happens regardless of the actual time. During a normal night of sleep, levels stay elevated for about 12 hours. As the sun rises, the pineal gland reduces production until the level in your blood is hardly measurable.

If you experience disruption to your circadian rhythms, your body will produce less melatonin and you will experience poor quality sleep. This can happen to those who work the night shift, have jet lag or are exposed to light during the night.

Melatonin Benefits More Than Sleep

A deficiency in this hormone may come with profound biological risks, such as potentially having higher levels of inflammation, a weaker immune system and an increased chance of developing cancer. The hormone interacts with receptor proteins that help control the different stages of sleep and are present in other organs and immune cells.2,3

Additionally, melatonin is a potent antioxidant that can raise the levels of other antioxidants, such as glutathione. Melatonin plays a role in the health and survival of mitochondria,4 your body’s powerhouse, where energy production takes place at a cellular level.

Melatonin has shown some promise for pain control in those suffering from endometriosis. In one study,5 10 mg per day decreased pain by 39.8% and dysmenorrhea by 38.01%. Topical application may help prevent sunburn,6 while oral supplementation was 150 times more effective at treating tinnitus as compared to other drugs. Melatonin may also play a protective role in:7

Delayed sleep phase syndrome Strengthening the blood-brain barrier Amyotrophic lateral sclerosis (ALS)
Reducing transplant complications Recovery from stroke and traumatic brain injury Diabetes
Vision and eye health Parkinson’s disease Thrombocytopenia
Gut health Jet lag Blood pressure and heart health
Acid reflux Aging Fertility

Boost Your Melatonin Naturally

Melatonin does come in supplemental form, but it’s also possible to raise your levels naturally. Researchers recognize nonpharmacological approaches to insomnia include better sleep hygiene, physical exercise and mindfulness meditation.

It makes sense to engage in simple habits to increase your natural production and improve your overall health and sleep without adding supplements. Four simple strategies include:

• Sunshine during the morning — Melatonin is affected by your exposure to light and dark. When it’s light, production of melatonin naturally drops. Getting at least 15 minutes of sunlight in the morning hours helps to regulate the production of melatonin, dropping it to normal daytime levels, so you feel awake during the day and sleep better at night.

• Sleep in the dark — Your body produces and secretes melatonin in the dark, helping you to go to sleep and stay asleep. Sleeping in a completely darkened room, without lights from alarm clocks, televisions or other sources will improve your sleep quality.

If you get up during the night to use the bathroom, it’s important to keep the lights off so you don’t shut off your production of melatonin. Also, wear blue-light blocking glasses after sunset to avoid blue-light exposure.

• Lower your stress level and your cortisol level — The release of melatonin is dependent on the release of another hormone, norepinephrine. Excess stress and the resulting release of cortisol inhibits the release of norepinephrine, and therefore the release of melatonin. Stress-reducing strategies you may find helpful before bed include yoga, stretching, meditation and prayer.

• Increase foods high in magnesium — Magnesium plays a role in reducing brain activity at night, helping you to relax and fall asleep more easily. It works in tandem with melatonin. Foods containing higher levels of magnesium include almonds, avocados, pumpkin seeds and green, leafy vegetables.

Supplementation and Potential Negative Effects

The beneficial effects associated with melatonin suggest it may primarily have a function as an antioxidant. In speaking with Time magazine, Helen Burgess, co-director of the Sleep and Circadian Research Laboratory at the University of Michigan, said:8

“Some of the emerging science is showing that in people with higher levels of inflammation — which could be because they’re obese, or because they’re in the [intensive care unit] for a transplant — melatonin in the range of 6 mg to 10 mg may decrease markers of inflammation.”

The authors of past studies have associated a deficiency in melatonin with obesity. It also may address inflammation, as supplementation has been associated with lowering oxidative stress and regulating adipokines involved in the inflammatory process. While believed to be relatively safe for up to 18 months, the long-term effects are largely unknown.

Possible negative interactions have been suggested for those with epilepsy or those taking Warfarin, a blood thinner. Melatonin is sometimes used in children to benefit those with sleep disorders, but long-term effects in children are also unknown. There has been some research suggesting that using melatonin during puberty may interfere with natural production of the hormone.

Researchers leading one study cautioned that supplementation should be limited in those with attention deficit hyperactivity disorder. They suggest considering the supplement only for those who also have chronic insomnia. It’s crucial to remember that melatonin is a hormone, and long-term supplementation with hormones can have unknown effects on the body.

In addition to the strategies listed above to boost your natural production, you may benefit from sleep habits information in my past article, “Top 33 Tips to Optimize Your Sleep Routine.”

 

 

 

 

 

Category:

Gut Health, Inflammation, Sleep, Supplements, Treatment

Living With Lyme – Bones, Mitochondria & Hypoxia – The Calcium Connection

https://www.evolutamente.it/living-with-lyme-bones-mitochondria-hypoxia-the-calcium-connection/  Full Article Here

By Doris Loh, independent researcher

It would appear that the ability of the Lyme spirochete to evade host immune responses, resist antimicrobial treatment, alter systemic metabolic functions and destroy mitochondrial function hinges upon the enhanced activity of hypoxia-inducible transcription factors HIF-1 and HIF-2, where HIF-1 alters metabolic pathways to favor glycolysis, and HIF-2 decreases osteoblast formation, resulting in chronic unresolved inflammation, bone loss and reduced mitochondrial functions.

Hypoxia-inducible transcription factors (HIF) are also heavily implicated in tumorigenesis, where HIF1a is found to be overexpressed in many cancers. Yet HIF is our body’s  primary response to fluctuations in cellular oxygen levels. How do our bodies control HIF regulation and why is Vitamin C, ascorbic acid, indispensable in the regulation of HIF?  ……… To Be Continued ……..

 

 

 

 

Category:

Inflammation, Lyme, research

Antiparasitic & Antifungl Medications Targeting Cancer Cells Repurposing Drugs For Cancer

https://www.linkedin.com/pulse/antiparasitic-antifungal-medications-targeting-cancer-yu-md/

Antiparasitic and Antifungal Medications Targeting Cancer Cells: Repurposing Drugs for Cancer

Published on October 7, 2019

Dr. Simon Yu, MD, Medical Director at Prevention and Healing,Inc.

Is it possible to treat cancer as a neglected infectious disease? Is cancer a metabolic disease, with tumors growing – and metastases spreading – like a metabolic parasite? It may sound farfetched, but there is growing evidence to support this novel idea that can change the way we treat many types of cancers.

Researching this topic in depth with Frederick T. Guilford, MD, we published a comprehensive article, “Antiparasitic and Antifungal Medications for Targeting Cancer Cells: Literature Review and Case Studies,” in the peer-reviewed journal, Alternative Therapies in Health and Medicine.

The Abstract concludes, “The information offered in this review suggests scientists should think of cancer not only as a metabolic disease but also as a metabolic parasite and should consider using antiparasitic medications under a new understanding of the role of inflammation, infection, and mitochondrial dysfunction in the development of cancer cells.”

Before discussing our latest paper, I would like to review the concept of an integrated program of mass drug administration (also referred to as preventive chemotherapy) to treat wide scale parasitic infections, published in The New England Journal of Medicine(NEJM) June 2019, “Collateral Benefits of Preventive Chemotherapy-Expanding the War on Neglected Tropical Diseases.”

The paper discusses how largescale administration of the antiparasitic medications albendazole, mebendazole, ivermectin, praziquantel and/or azithromycin in the early 2000’s – reaching over 1 billion people per year in Africa, Asia and Latin America for the original targets of parasitic diseases – had an unintended outcome of collateral health benefits. In addition to greatly reducing the incidence of parasitic diseases and disability and saving many lives on a mass scale, it provided a form of universal health coverage, including reducing transmission of malaria. A thought provoking idea!

Going back to our paper, chronic inflammation is a new catchphrase for the explanation of all chronic degenerative diseases, from asthma, arthritis, heart disease, autoimmune disease, and irritable bowel disease to cancer. Unrecognized low-grade infection is a main cause of inflammation from oncovirus, bacterial, fungal and lesser-known parasite infections that are driving forces in the cellular evolution and degeneration of cancer cells.

The observation that cancers, like parasites, feed off of our bodies without returning a benefit has been known for some time, and early in the 20th century, it was suggested that cancer is a parasite. The metabolism of some parasites shows a method of energy formation similar to that of cancer cells.

An approach using currently available medications that target both fungal and parasite metabolism appears to interfere with tumor growth and aggressiveness.

Due to the complexity of the behavior and biology of the cells, scientists’ primary focus should be on detection and elimination of sources of inflammation. Physicians should think of cancer not only as a metabolic disease but also as a metabolic parasite, and should also consider using antiparasitic and antifungal medications with the understanding of the role of inflammation, infection and mitochondrial dysfunction in the development of cancer cells.

For more on this line of thinking, see Thomas Seyfried, Ph.D. et al’s article in Carcinogenesis, “Cancer as a Metabolic Disease: Implications for Novel Therapeutics,” and R. Lamb et al’s research paper in Oncotarget in 2015, “Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Targeting cancer like an infectious disease.”

In my practice, I have learned over the years that many unsuspected chronic illnesses – and some cancers – are caused by parasites. A few years ago, I wrote, “Cancer is an Infectious Disease as if Cancer is Metabolic Parasites: Evolution and Degeneration of Biology of Cancer Cells,” reviewing Seyfried’s work.

I have also learned that there is much research to be done on how our cells and our ancestral microbes share commonalities as well as differences in how they function in health and disease to this day – providing potential new avenues for treatment. One of my favorite phrases is, “We are not so different, you and I.” It applies not only across people and cultures, but across cells, microorganisms, and all of God’s creatures, great and small.

Our position in the paper is analogous to NEJM’s recent article, “Collateral Benefits of Preventive Chemotherapy-Expanding the War on Neglected Tropical Diseases,” regarding the unintended outcome of extended collateral benefits of saving lives on a mass scale, if mainstream academic medicine is willing to embrace the concept of cancer as infectious diseases as if cancer is metabolic parasites.

In my cancer and complex chronic disease patients, I have been extensively using parasite medications (such as albendazole, mebendazole, ivermectin, and praziquantel), antibiotics and antifungal medications, and making referrals to biological dentists to eradicate hidden dental infections (especially Entamoeba and protozoal parasites). As patients recover healthy metabolic and immune functioning, it is not uncommon to witness the resolution of many chronic diseases, including asthma, autism, Lyme, persistent Lyme, psoriasis, neurologic disorders like MS and Parkinson’s, seizures, and cancers.

I am not in a position to claim that cancer is an infectious disease. I think it is worth asking the question if it is possible to treat cancer as a neglected infectious disease, as if cancer is a metabolic parasite. Dr. Guilford and I are interested in collaborating and testing our hypothesis for Preventive Chemotherapy using parasite medications for cancer. Time to think differently!

Dr. Simon Yu, M.D. is a Board Certified Internist. He practices Internal Medicine with an emphasis on Integrative Medicine to use the best each has to offer. For more articles and information about integrative medicine, patient success stories, and Dr. Yu’s new book, AcciDental Blow Up in Medicine: Battle Plan for Your Life, visit his website at www.preventionandhealing.com or call Prevention and Healing, Inc., 314-432-7802. You can also attend a free monthly presentation and discussion by on Integrative Medicine at his office on the second Tuesday each month at 6:30 pm. Call to verify the date. Seating is limited, arrive early.

_____________________

For more: https://madisonarealymesupportgroup.com/2019/08/18/parasites-the-immune-system/

https://madisonarealymesupportgroup.com/2017/10/03/removing-parasites-to-fix-lyme-chronic-illnesses-dr-jay-davidson/

https://madisonarealymesupportgroup.com/2019/05/21/free-antigerm-action-plans-for-lyme-disease-how-to-use-herbal-prescription-germ-killers-for-bacteria-parasites-viruses-yeast/

https://madisonarealymesupportgroup.com/2019/09/06/the-macabre-world-of-mind-controlling-parasites/

https://madisonarealymesupportgroup.com/2017/03/23/rebecca-keith-on-mcas-parasites-lymemsids/

https://www.cancertreatmentsresearch.com/fenbendazole/

Category:

Activism, Inflammation, Parasites, research, Treatment

Search

Archives

Lyme Non-Profits

  • Wisconsin Lyme Network Facebook

Lyme Resources

  • Affordable Blood Draws/injections in Wisconsin
  • Blood Draws in Madison
  • Columbia Specimen Bank 646-774-7503
  • Dental Care For Children With Autism
  • Find a Lyme Support Group
  • IGeneX, Inc. (lab testing)
  • ILADS (International Lyme And Associated Diseases Society)
  • Learn about Lyme
  • Lyme Bio Bank (NDRI & Bay Area Lyme Foundation)
  • Lyme Curriculum & Educational Activities
  • Lyme Disease Association
  • Lyme Info
  • Lyme Resource Zip File
  • Lyme-Symptoms
  • Lymedisease.org (Formally CALDA)
  • LymeLight Foundation
  • National Suicide Hotline
  • On-line Mental Health Therapy
  • SE Wisconsin Support Group
  • Substance Abuse Rehab Centers in Wisconsin
  • Substance Misuse Support
  • Suicide & Social Media
  • Tick borne disease education
  • Tick Borne Disease Prevention: Stuff for Kids
  • Tick Prevention
  • Tick-Borne Disease Alliance
  • TRUTHCURES
  • What is Lyme

Online Support Groups

  • Lyme Support Group of Southeast Wisconsin (Facebook)
  • Military Lyme Info
  • Military Lyme Support (Facebook)
  • Parents Whose Children Have Lyme/MSIDS
  • Wisconsin/Illinios Lyme (Facebook)

Visitors

  • 8,075,729

Top Posts & Pages

  • Proof That the Pandemic Was Planned & With Purpose
  • Understanding Alpha-gal Syndrome and Its Growing Geographic Overlap With Lyme Disease
  • Lyme - The Human Torture Chamber
  • Baby Dies After 6 Vaccines to 'Catch Up' & 50% of SIDS Happened Within 48 Hours of Vaccination - But No One Can Say It Out Loud
  • Chlamydia Trachomatis & Lyme Disease
  • Doctor Exonerated For Recommending Natural Remedies for COVID But Others Still Being Persecuted & New Zealand's Scandal
  • First Cancer Protocol using Ivermectin, Mebendazole, and Fenbendazole Published
  • Former French Health Minister Blows Whistle: Criminal Pressure From BigPharma on Publications Means There's No Longer Any Real Science
  • Ivermectin's Accidental Breakthrough: Parkinson's & Alzheimer's
  • Epstein & Gates Financed Research Portal To Control Scientific Discourse

Categories

  • Activism
  • Adrenals
  • Allodynia
  • Alpha Gal Meat Allergy
  • Alzheimer's
  • Anaplasmosis
  • Anaplasmosis Treatment
  • Autism
  • Babesia
  • Babesia Treatment
  • Bartonella
  • Bartonella Treatment
  • Biofilm
  • Borrelia Miyamotoi (Relapsing Fever Group)
  • C-diff
  • Cancer
  • Candida
  • Chiropractic Care for MSIDS
  • Climate
  • Clinic
  • Corrections
  • Dentistry
  • Detoxing
  • diet and nutrition
  • Disability
  • Educational handouts
  • Ehrlichiosis
  • Ehrlichiosis Treatment
  • EMF
  • Eye Issues
  • Genetic Mutations
  • Gut Health
  • Hearing Loss
  • Heart Issues
  • Hemp Oil
  • Herbs
  • Hormones
  • Hyperthermia
  • Inflammation
  • Interstitial Cystitis
  • Lyme
  • Lyme Disease Treatment
  • Lyme Vaccine
  • Malaria
  • Marijuana
  • Mast Cell Activation Syndrome (MCAS)
  • Meetings
  • Mold
  • Morgellons
  • mosquitoes
  • Mycoplasma
  • Mycoplasma Treatment
  • Pain Management
  • PANS
  • Parasite Treatment
  • Parasites
  • Pregnancy
  • Prevention
  • Psychological Aspects
  • Q Fever
  • research
  • Rickettsia
  • Rocky Mountain Spotted Fever
  • Sleep
  • Supplements
  • Support Group Presentations
  • Syphilis
  • Testing
  • thyroid
  • Tickborne Relapsing Fever
  • Ticks
  • Toxoplasmosis
  • Transmission
  • Treatment
  • Tularemia
  • Uncategorized
  • vaccines
  • Viruses
  • Zika

Older Posts

Newer Posts

Madison Area Lyme Support Group
  • Subscribe Subscribed
    • Madison Area Lyme Support Group
    • Join 685 other subscribers
    • Already have a WordPress.com account? Log in now.
    • Madison Area Lyme Support Group
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...